OR WAIT null SECS
January 05, 2021
Angelini will obtain an exclusive license to commercialize Arvelle’s investigational anti-seizure medication, cenobamate, in the European Union and other countries in the European Economic Area.
January 04, 2021
Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.
The companies have entered into an agreement to support the formulation and fill/finish of Moderna’s COVID-19 vaccine supply outside of the United States.
Honeywell will use Sparta’s expertise to introduce new QMS solutions for life sciences to its customer base.
Part of Operation Warp Speed, the trial will enroll 30,000 people ages 18 to 64 and 65 and older at 115 sites.
January 03, 2021
Despite the COVID-19 pandemic disruptions, with continued support and industry resilience, the European bio/pharma outlook for 2021 is positive.
January 02, 2021
The recently published European pharmaceutical strategy is being seen as an opportunity to strengthen medicines regulation in the region.
The outlook for the European pharma industry is appearing to be favourable overall.
January 01, 2021
Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors.
December 31, 2020
Commissioner Stephen Hahn evaluates the agency’s response to COVID-19 and how it affected non-COVID related initiatives in 2020.
